Mylan, Watson cleared to market Boniva generic
Mylan Inc. and Watson Pharmaceuticals Inc. have received approval from the Food and Drug Administration to launch a generic version of Roche’s Boniva osteoporosis medication. Mylan said Tuesday that its Mylan Pharmaceuticals Inc. has begun shipping ibandronate sodium tablets 150 mg.